Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
Status:
NOT_YET_RECRUITING
Trial end date:
2028-10-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to compare the efficacy and safety of low-dose and internationally recommended standard dose of selumetinib in the treatment of plexiform neurofibromas in Chinese children.